Regulation of Osteoblast Formation and Function

Reviews in Endocrine and Metabolic Disorders

Volumn 2, Issue 1, 2001, Pages 81-94

  Aubin, Jane E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone; Heterogeneity; Multi potential; Osteoprogenitor; Stem cell

Indexed keywords

ANIMAL; BONE; BONE DEVELOPMENT; CYTOLOGY; HUMAN; OSTEOBLAST; PHYSIOLOGY; REVIEW;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; HUMANS; OSTEOBLASTS;

EID: 0035236997     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010011209064     Document Type: Article

References (71)

1. Friedenstein AJ. Osteogenic stem cells in the bone marrow, In: Heersche JNM, Kanis JA, eds. Bone Min Res/7. Elsevier Science Publishers B.V. (Biomedical Division), 1990:243-270.
2. Owen ME. The marrow stromal cell system, In: Beresford JN, Owen ME, eds. Marrow stromal stem cells in culture, vol IV. Cambridge: Cambridge University Press, 1998:88-110.
3. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-74.
4. Morrison SJ, Shah NM, Anderson DJ. Regulatory mechanisms in stem cell biology. Cell 1997;88:287-298.
5. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:141-147.
6. Aubin JE. Bone stem cells. 25th Anniversary Issue: New directions and dimensions in cellular biochemistry. Invited chapter. J Cell Biochem 1998;Suppl. 30/31:73-82.
7. Aubin JE. Osteoprogenitor cell frequency in rat bone marrow stromal cell populations: Role for heterotypic cell-cell interactions in osteoblast differentiation. J Cell Biochem 1999;72:396-410.
8. Eaves C, Miller C, Conneally E, Audet J, Oostendorp R, Cashman J, Zandstra P, Rose-John S, Piret J, Eaves A. Introduction to stem cell biology in vitro. Threshold to the future. Ann NY Acad Sci 1999;872:1-8.
9. 9a. Gimble JM, Robinson CE, Kelly KA. The function of adipocytes in the bone marrow stroma: An update. Bone 1996;19(5):421-428.
10. 9b. Park SR, Oreffo RO, Triffitt JT. Interconversion potential of cloned human marrow adipocytes in vitro. Bone 1999;24(6):549-554.
11. Nuttall ME, Patton AJ, Olivera DL, Nadeau DP, Gowen M. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: Implications for osteogenic disorders. J Bone Miner Res 1998;13:371-382.
12. Aubin JE, Heersche JMN. Vitamin D and osteoblasts. In: Feldman D, Glorieux FH, Pike JW, eds. Vitamin D. San Diego: Academic Press 1997;313-328.
13. Cancedda R, Descalzi Cancedda F, Castagnola P. Chondrocyte differentiation. Int Rev Cytol 1995;159:265-357.
14. Roach HI, Erenpreisa J, Aigner T. Osteogenic differentiation of hypertrophic chondrocytes involves asymmetric cell divisions and apoptosis. J Cell Biol 1995;131(2):483-494.
15. Chen Q, Johnson DM, Haudenschild DR, Goetinck PF. Progression and recapitulation of the chondrocyte differentiation program: Cartilage matrix protein is a marker for cartilage maturation. Dev Biol 1995;172:293-306.
16. Lui VCH, Ng LJ, Nicholls J, Tam PPL, Cheah KSE. Tissue-specific and differential expression of alternatively spliced alpha1(II) collagen mRNAs in early human embryos. Dev Dyn 1995;203:198-211.
17. Wu Z, Puigserver P, Spiegelman BM. Transcriptional activation of adipogenesis. Curr Opin Cell Biol 1999;11(6):689-694.
18. Karsenty G. The genetic transformation of bone biology. Genes Dev 1999;13(23):3037-3051.
19. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 1999;13(8):1025-1036.
20. Lecka-Czernik B, Gubrij I, Moerman EJ, Kajkenova O, Lipschitz DA, Manolagas SC, Jilka AL. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. J Cell Biochem 1999;74(3):357-371.
21. St-Jacques B, Hammerschmidt M, McMahon AP. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation [published erratum appears in Genes Dev 1999 Oct 1;13(19):2617]. Genes Dev 1999;13(16):2072-2086.
22. Chuang PT, McMahon AP. Vertebrate Hedgehog signaling modulated by induction of a hedgehog-binding protein. Nature 1999;397(6720):617-621.
23. Hofbauer LC, Khosla S, Dunstan CR, Lacey D, Boyle WJ, Riggs BL. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000;15(1):2-12.
24. Turksen K, Aubin JE. Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells. J Cell Biol 1991;114(2):373-384.
25. Ishida Y, Heersche JN. Progesterone stimulates proliferation and differentiation of osteoprogenitor cells in bone cell populations derived from adult female but not from adult male rats. Bone 1997;20(1):17-25.
26. Hughes FJ, Collyer J, Stanfield M, Goodman SA. The effects of Bone Morphogenetic Protein -2, -4 and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 1995;136:2671-2677.
27. Malaval L, Modrowski D, Gupta AK, Modrowski D, Gupta AK, Aubin JE. Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. J Cell Physiol 1994;158:555-572.
28. Doherty MJ, Canfield AE. Gene expression during vascular pericyte differentiation. Crit Rev Eukaryot Gene Expr 1999;9(1):1-17.
29. Scutt A, Bertram P. Bone marrow cells are targets for the anabolic actions of PGE2 on bone: Induction of a transition from nonadherent to adherent osteoblast precursors. J Bone Miner Res 1995;10(3):474-487.
30. Long MW, Robinson JA, Mann KG. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest 1995;95(2):881-887.
31. Aubin JE, Liu F. The osteoblast lineage. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology. San Diego: Academic Press, 1996:51-67.
32. Malaval L, Liu F, Roche P, Aubin JE. Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro. J Cell Biochem 1999;74:616-627.
33. Ramsfjell V, Bryder D, Bjorgvinsdottir H, Kornfalt S, Nilsson L, Borge OJ, Jacobsen SE. Distinct requirements for optimal growth and in vitro expansion of human CD34(+)CD38(-) bone marrow long-term culture-initiating cells (LTC-IC), extended LTC-IC, and murine in vivo long-term reconstituting stem cells. Blood 1999;94(12):4093-4102.
34. Stein GS, Lian JB, Stein JL, van Wijnen AJ, Frenkel B, Montecino M. Mechanisms regulating osteoblast proliferation and differentiation. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology. San Diego: Academic Press, 1996:69-86.
35. Liu F, Aubin JE. Identification and molecular characterization of preosteoblasts in the osteoblast differentiation sequence. J Bone Miner Res 1994;9(Suppl. 1):S125.
36. Liu F, Aubin JE. Low density replica plating and global amplification PCR reveals novel transitional stages in osteoprogenitor cells undergoing differentiation in vitro. Submitted 2000.
37. Candeliere GA, Rao Y, Floh A, Sandler SD, Aubin JE. cDNA fingerprinting of osteoprogenitor cells to isolate differentiation stage-specific genes. Nucl Acids Res 1999;27:1079-1083.
38. Aubin JE, Gupta AK, Zirngbl R, Rossant J. Knockout mice lacking bone sialoprotein expression have bone abnormalities. J Bone Miner Res 1996;11(Suppl. 1):S102.
39. Liu F, Malaval L, Aubin JE. The mature osteoblast phenotype is characterized by extensive palsticity. Exp Cell Res 1997;232:97-105.
40. Candeliere GA, Liu F, Aubin JE. Heterogeneity of marker expression by osteoblasts in different zones of bone in the 21 day fetal rat calvaria. J Bone Miner Res 1997;12(Suppl. 1):S187.
41. Aubin JE, Candeliere GA, Bonnelye E. Heterogeneity of the osteoblast phenotype. The Endocrinologist 1999;9:25-31.
42. Onoe Y, Miyaura C, Ohta H, Nozawa S, Suda T. Expression of estrogen receptor β in rat bone. Endocrinology 1997;138:4509-4512.
43. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 2000;100(2):197-207.
44. Rodan GA. Control of bone formation and resorption: biological and clinical perspective. 25th Anniversary Issue: New directions and dimensions in cellular biochemistry. J Cell Biochem 1998;Suppl. 30/31:55-61.
45. Ellies LG, Aubin JE. Temporal sequence of interleukin 1α-mediated stimulation and inhibition of bone formation by isolated fetal rat calvarial cells in vitro. Cytokine 1990;2(6):430-437.
46. Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, Yamaguchi A. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 1997;99(12):2961-2970.
47. Bellows CG, Ishida H, Aubin JE, Heersche JNM. Parathyroid hormone reversibly suppresses the differentiation of osteoprogenitor cells into functional osteoblasts. Endocrinology 1990;127:3111-3116.
48. Karaplis AC, Kronenberg HM. Physiological roles for parathyroid hormone-related protein: lessons from gene knockout mice. Vitam Horm 1996;52:177-193.
49. Lanske B, Amling M, Neff L, Guiducci J, Baron R, Kronenberg HM. Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J Clin Invest 1999;104(4):399-407.
50. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone [see comments]. J Clin Invest 1999;104(4):439-446.
51. Malaval L, Gupta AK, Liu F, Delmas PD, Aubin JE. Lif, but not IL-6, regulates osteoprogenitor differentiation: Modulation by dexamethasone. J Bone Miner Res 1998;13:175-184.
52. Zandstra PW, Jervis E, Haynes CA, Kilburn DG, Eaves CJ, Piret JM. Concentration-dependent internalization of a cytokine/cytokine receptor complex in human hematopoietic cells. Biotechnol Bioeng 1999;63(4):493-501.
53. Bonewald LF. Transforming growth factor-β. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology. San Diego: Academic Press, 1996:647-659.
54. Erlebacher A, Derynck R. Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 1996;132(1-2):195-210.
55. Erlebacher A, Filvaroff EH, Ye JQ, Derynck R. Osteoblastic responses to TGF-beta during bone remodeling. Mol Biol Cell 1998;9(7):1903-1918.
56. Filvaroff E, Erlebacher A, Ye J, Gitelman SE, Lotz J, Heillman M, Derynck R. Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Develop 1999;126(19):4267-4279.
57. Lukert BP, Kream BE. Clinical and basic aspects of glucocorticoid action in bone. In: Bilezikian JP, Riasz LG, Rodan GA, eds. Principles of Bone Biology San Diego: Academic Press, 1996:533-548.
58. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998;102(2):274-282.
59. Boden SD, Hair G, Titus L, Racine M, McCuaig K, Wozney JM, Nanes MS. Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6. Endocrinology 1997;138:2820-2828.
60. Jikko A, Harris SE, Chen D, Mendrick DL, Damsky CH. Collagen integrin receptors regulate early osteoblast differentiation induced by BMP-2. J Bone Miner Res 1999;14(7):1075-1083.
61. Xiao G, Cui Y, Ducy P, Karsenty G, Franceschi RT. Ascorbic acid-dependent activation of the osteocalcin promoter in MC3T3- E1 preosteoblasts: Requirement for collagen matrix synthesis and the presence of an intact OSE2 sequence. Mol Endocrinology 1997;11(8):1103-1113.
62. Xiao G, Wang D, Benson MD, Karsenty G, Franceschi RT. Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J Biol Chem 1998;273(49):32988-32994.
63. Celic S, Katayama Y, Chilco PJ, Martin TJ, Findlay DM. Type I collagen influence on gene expression in UMR-106 osteoblast-like cells in inhibited by genistein. J Endocrinol 1998;158:377-388.
64. Wenstrup RJ, Witte DP, Florer JB. Abnormal differentiation in MC3T3-E1 preosteoblasts expressing a dominant-negative type I collagen mutation. Connect Tissue Res 1996;35(1-4):249-257.
65. Moursi AM, Damsky CH, Lull J, Zimmerman D, Doty SB, Aota S, Globus RK. Fibronectin regulates calvarial osteoblast differentiation. J Cell Sci 1996;109(Pt 6):1369-1380.
66. Bellows CG, Aubin JE, Heersche JNM. Initiation and progression of mineralization of bone nodules formed in vitro: The role of alkaline phosphatase and organic phosphate. Bone Miner 1991;14:27-40.
67. Whyte MP. Hypophosphatasia: Nature's window on alkaline phosphatase function in man. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology. San Diego: Academic Press, 1996:951-968.
68. Fedde KN, Blair L, Silverstein J, Coburn SP, Ryan LM, Weinstein RS, Waymire K, Narisawa S, Millan JL, MacGregor GR, Whyte MP. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 1999;14(12):2015-2026.
69. Hui MZ, Sukhu B, Tenenbaum HC. Expression of tissue non-specific alkaline phosphatase stimulates differentiated behavior in specific transformed cell populations. Anat Rec 1996;244(4):423-436.
70. MacGregor GR, Zambrowicz BP, Soriano P. Tissue non-specific alkaline phosphatase is expressed in both embryonic and extraembryonic lineages during mouse embryogenesis but is not required for migration of primordial germ cells. Develop 1995;121:1487-1496.
71. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G. Increased bone formation in osteocalcin-deficient mice. Nature 1996;382:448-452.